The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis

• Mikuto Tojima,
• Yasufumi Katanasaka,
• Yoichi Sunagawa,
• Koji Hasegawa,
• Tatsuya Morimoto

Affiliations

Mikuto Tojima

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

Yasufumi Katanasaka

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, Japan

Yoichi Sunagawa

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, Japan

Koji Hasegawa

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Kyoto Medical Center, Kyoto, Japan

Tatsuya Morimoto

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Division of Translational Research, Kyoto Medical Center, Kyoto, Japan; Shizuoka General Hospital, Shizuoka, Japan